Matrix Metalloproteinase Induction by Relaxin Causes Cartilage Matrix Degradation in Target Synovial Joints

Our long‐term goal is to understand the mechanisms by which relaxin and estrogen potentially contribute to joint diseases, particularly those afflicting the fibrocartilaginous temporomandibular joint (TMJ). Previously, we showed that relaxin produces a dose‐dependent induction of tissue‐degrading enzymes of the matrix metalloproteinase (MMP) family, specifically MMP‐1 (collagenase‐1), MMP‐3 (stromelysin‐1), MMP‐9 (92‐kDa gelatinase), and MMP‐13 (collagenase‐3) in cell isolates and tissue explants from TMJ fibrocartilage. The induction of these MMPs is accompanied by loss of collagen and glycosaminoglycans (GAGs), which was blocked by a pan‐MMP inhibitor. We also found the targeted in vivo loss of collagen and GAGs in TMJ discs of ovariectomized rabbits treated with β‐estradiol, relaxin, or both hormones together. Progesterone attenuated the induction of MMPs and matrix loss by relaxin and estrogen. The modulation of matrix composition in TMJ fibrocartilage by these hormones was similar to that observed in the pubic symphysis and differed from that of the knee meniscus. The two target tissues showing the greatest modulation of MMPs and matrix loss, namely, the TMJ disc and pubic symphysis, had similar expression profiles of the estrogen receptors α and β, relaxin‐1 receptor (RXFP1, LGR7), and insulin‐like peptide 3 receptor (RXFP2, LGR8) and these profiles differed from those in cells from the knee meniscus. These findings suggest a novel model for targeted tissue turnover of cartilage of specific joints through hormone‐mediated induction of select MMPs.

[1]  G. Striker,et al.  Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. , 2001, Journal of the American Society of Nephrology : JASN.

[2]  J. Wade,et al.  INSL3/Leydig Insulin-like Peptide Activates the LGR8 Receptor Important in Testis Descent* , 2002, The Journal of Biological Chemistry.

[3]  S. Yagel,et al.  Expression of gelatinase B by trophoblast cells: down-regulation by progesterone. , 1998, American journal of obstetrics and gynecology.

[4]  A. Hsueh,et al.  Activation of Orphan Receptors by the Hormone Relaxin , 2002, Science.

[5]  J. Lipton,et al.  Estimated prevalence and distribution of reported orofacial pain in the United States. , 1993, Journal of the American Dental Association.

[6]  E. Rorke,et al.  Relaxin modulates human cervical stromal cell activity. , 1996, The Journal of clinical endocrinology and metabolism.

[7]  S. Kapila,et al.  Relaxin's induction of metalloproteinases is associated with the loss of collagen and glycosaminoglycans in synovial joint fibrocartilaginous explants , 2004, Arthritis research & therapy.

[8]  L. Parry,et al.  Physiological or pathological--a role for relaxin in the cardiovascular system? , 2003, Current opinion in pharmacology.

[9]  D. Hart,et al.  Estrogen receptor alpha regulates matrix metalloproteinase-13 promoter activity primarily through the AP-1 transcriptional regulatory site. , 2006, Biochimica et biophysica acta.

[10]  L. Salamonsen,et al.  Progestin suppresses matrix metalloproteinase production in endometrial cancer. , 2003, Gynecologic oncology.

[11]  S. Kapila,et al.  Does the relaxin, estrogen and matrix metalloproteinase axis contribute to degradation of TMJ fibrocartilage? , 2003, Journal of musculoskeletal & neuronal interactions.

[12]  E. Amento,et al.  Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. , 1996, The Journal of clinical investigation.

[13]  S. Kapila,et al.  Relaxin and β-estradiol modulate targeted matrix degradation in specific synovial joint fibrocartilages: progesterone prevents matrix loss , 2006, Arthritis research & therapy.

[14]  E. Wintour,et al.  Collagen Studies in Late Pregnant Relaxin Null Mice1 , 2000, Biology of reproduction.

[15]  R. Meech,et al.  BARX2 and estrogen receptor-α (ESR1) coordinately regulate the production of alternatively spliced ESR1 isoforms and control breast cancer cell growth and invasion , 2006, Oncogene.

[16]  G. Sotereanos,et al.  Estrogen and progesterone receptors in temporomandibular joint discs of symptomatic and asymptomatic persons: a preliminary study. , 1993, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[17]  E. Amento,et al.  Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. , 1990, The Journal of biological chemistry.

[18]  M. Warren,et al.  Temporomandibular Disorders and Hormones in Women , 2001, Cells Tissues Organs.

[19]  Tsuyoshi Saito,et al.  Acceleration of invasive activity via matrix metalloproteinases by transfection of the estrogen receptor‐α gene in endometrial carcinoma cells , 2002, International journal of cancer.

[20]  M. Nevitt,et al.  The effects of estrogen on osteoarthritis. , 1998, Current opinion in rheumatology.

[21]  S. Milam,et al.  Sexual dimorphism in the distribution of estrogen receptors in the temporomandibular joint complex of the baboon. , 1987, Oral surgery, oral medicine, and oral pathology.

[22]  B. Monia,et al.  Relaxin positively regulates matrix metalloproteinase expression in human lower uterine segment fibroblasts using a tyrosine kinase signaling pathway. , 2001, Endocrinology.

[23]  J. Bateman,et al.  The effect of relaxin on collagen metabolism in the nonpregnant rat pubic symphysis: the influence of estrogen and progesterone in regulating relaxin activity. , 1996, Endocrinology.

[24]  S. Kapila,et al.  Targeted induction of collagenase and stromelysin by relaxin in unprimed and beta-estradiol-primed diarthrodial joint fibrocartilaginous cells but not in synoviocytes. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[25]  M. Rajabi,et al.  Relaxin stimulates interstitial collagenase activity in cultured uterine cervical cells from nonpregnant and pregnant but not immature guinea pigs; estradiol-17 beta restores relaxin's effect in immature cervical cells. , 1995, Biology of reproduction.

[26]  K. Osteen,et al.  Progesterone exposure prevents matrix metalloproteinase-3 (MMP-3) stimulation by interleukin-1alpha in human endometrial stromal cells. , 2000, The Journal of clinical endocrinology and metabolism.

[27]  M. Krajnc-Franken,et al.  Impaired Nipple Development and Parturition in LGR7 Knockout Mice , 2004, Molecular and Cellular Biology.

[28]  S. Kapila,et al.  Female hormone receptors are differentially expressed in mouse fibrocartilages. , 2009, Osteoarthritis and cartilage.

[29]  Scott W Cousins,et al.  Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. , 2003, Investigative ophthalmology & visual science.

[30]  C. Wira,et al.  Effect of Estradiol on Mouse Uterine Epithelial Cell Transepithelial Resistance (TER) , 2004, American journal of reproductive immunology.

[31]  Michael Von Korff,et al.  An epidemiologic comparison of pain complaints , 1988, Pain.

[32]  T. Iwanaga,et al.  Expression of estrogen receptor alpha (ER alpha) in the rat temporomandibular joint. , 2003, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[33]  D. Woolley,et al.  Menstruation: induction by matrix metalloproteinases and inflammatory cells. , 1999, Journal of reproductive immunology.

[34]  J. Bateman,et al.  Effects of relaxin, pregnancy and parturition on collagen metabolism in the rat pubic symphysis. , 1998, The Journal of endocrinology.